Related Experiment Videos
[Plasma calcitonin and breast tumors]
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1984
Summary
Elevated calcitonin levels may indicate bone metastasis in breast cancer patients, though it is not a constant marker. Further research is needed to understand this relationship.
Area of Science:
- Oncology
- Endocrinology
- Biochemistry
Context:
- Breast carcinoma is a prevalent cancer.
- Bone metastasis significantly impacts patient prognosis.
- Circulating calcitonin levels are investigated as a potential biomarker.
Purpose:
- To determine the frequency of elevated plasma calcitonin in breast cancer patients with bone metastasis.
- To compare calcitonin levels in patients with and without bone metastasis.
Summary:
- Plasma calcitonin was measured in 32 breast carcinoma patients (with and without bone metastasis).
- Normal calcitonin levels were observed in all patients without metastasis.
- Elevated calcitonin was found in 2 of the 6 patients with bone metastasis; 4 had normal levels.
Impact:
- Suggests a correlation between elevated calcitonin and bone metastasis in breast cancer.
- Highlights that elevated calcitonin is not a universal finding in bone metastasis.
- Informs potential diagnostic or prognostic strategies for breast cancer bone metastasis.